Complete anonymity & PGP-encrypted customer data
Blog

PCT after SARMs regimen: the right protocol for testosterone recovery

Quick AI Summary

> **Disclaimer:** This article is for educational and research purposes only. The content encourages...

PCT after SARMs regimen: the right protocol for testosterone recovery

May 8

PCT after SARMs regimen: the right protocol for testosterone recovery

Disclaimer: This article is for educational and research purposes only. The content does not encourage the use of illegal substances or prescription drugs without a doctor’s prescription. Always consult a qualified physician before starting any hormonal protocol.

SARMs (selective androgen receptor modulators) suppress the body’s endogenous testosterone production to varying degrees — a fact that every person researching these substances must be aware of. Without a well-planned PCT after SARMs, one risks weeks, sometimes months, of low testosterone with all that entails: muscle loss, depression, decreased libido and metabolic disturbances. This protocol gives you an evidence-based overview of how recovery works and what the research actually says.

How do SARMs suppress testosterone production in the body?

The short answer: SARMs bind to androgen receptors and signal the hypothalamus to reduce GnRH secretion, which lowers LH/FSH and thus testosterone production in the testicles.

SARMs activate androgen receptors in a tissue-selective manner, but the negative feedback on the hypothalamic-pituitary-gonadal axis (HPG axis) remains. When the brain “sees” sufficient androgen levels via the receptors, it decreases gonadotropin release — LH (luteinizing hormone) and FSH fall, and the Leydig cells in the testicles stop producing testosterone in normal amounts.

The degree of suppression varies markedly between different SARMs. A study published in the Journal of Pharmacology and Experimental Therapeutics (2010) showed that LGD-4033 at 1 mg/day for 21 days lowered total testosterone by an average of 55% and SHBG by 22%. RAD-140 and YK-11 are considered to provide even stronger suppression, while Ostarine (MK-2866) at low doses (below 15 mg/day) provides a relatively mild effect.

The crucial thing is to understand that suppression is not the same as total shutdown. The HPG axis usually recovers spontaneously within 4–8 weeks of stopping the course for the mildest SARMs, but a full SARM recovery may require active PCT for the stronger options. Without intervention, several case reports show that testosterone levels can remain suboptimal for 3–6 months.

Which drugs are used in post cycle therapy after SARMs?

The short answer: Nolvadex (tamoxifen) and clomiphene are the most common PCT drugs; they block estrogen receptors in the hypothalamus and stimulate LH/FSH release.

Nolvadex in SARMs recovery

Nolvadex sarms is the combination that comes up the most in scientific discussions about PCT. Tamoxifen is a selective estrogen receptor modulator (SERM) that blocks estrogen receptors in the hypothalamus and pituitary gland. It is perceived by the brain as an estrogen-deficient state, which triggers increased GnRH, LH and FSH release — exactly the signaling cascade you want to restore after a SARMs regimen.

Typical dosing protocols in clinical and case report settings are 20–40 mg/day for the first two weeks, followed by 10–20 mg/day for another two weeks. A report in BMJ Case Reports (2018) documented successful testosterone recovery with tamoxifen in a patient with SARMs-induced hypogonadism.

Clomiphene as an alternative or supplement

Clomiphene PCT works in a similar way but blocks estrogen receptors in the hypothalamus more selectively. It often produces a stronger LH surge than tamoxifen, but the side effect profile sometimes includes visual disturbances and emotional instability. Standard dosage in the context of PCT is 25–50 mg/day for 4 weeks, with a possible tapering in the last week.

Some protocols combine low doses of both SERMs for the first two weeks for maximal stimulation of the HPG axis, but randomized controlled trials comparing monotherapy versus combination therapy specifically for SARMs-induced suppression are lacking.

Which PCT protocol fits which SARMs regimen?

The short answer: The choice of PCT intensity is based on the degree of suppression of the substance, course length and individual laboratory values — not on general network recommendations.

Below is an evidence-informed overview based on the clinical literature and case reports available as of 2024. Note that none of these substances are approved for human use in most countries.

SARMs regimenDegree of suppressionRecommended PCTLength

|Ostarine ≤15 mg/day, ≤6 y|Mild|Nolvadex 10–20 mg/day|4 weeks|

|Ostarine >25 mg/day, >8 yrs|Moderate|Nolvadex 20–40 mg/day|4–6 weeks|

|LGD-4033, Ligandrol|Powerful|Nolvadex 40/40/20/20 mg|4 weeks|

|RAD-140, Testolone|Strong–Severe|Clomiphene 50/50/25/25 mg or combination|6 weeks|

|YK-11, S23|Serious|Clomiphene + Nolvadex, doctor contact|6–8 weeks|

|Stacked courses|Very varied|Individually based on blood values|At least 6 weeks|

Blood sampling before, during and after the course is the only way to objectively assess whether post cycle therapy is working. The relevant measures are total testosterone, free testosterone, LH, FSH, SHBG and estradiol. Normalization is usually defined as total testosterone returning to the reference range (300–1000 ng/dL depending on lab) and LH exceeding 1.5 IU/L.

What to do during PCT to optimize testosterone recovery?

The short answer: Sleep quality, caloric intake, zinc, vitamin D, and low-intensity exercise enhance HPG axis recovery — avoid alcohol and severe caloric deficit.

PCT is not just a pharmaceutical issue. Lifestyle factors during the recovery period affect the speed and quality of SARM recovery at least as much as the choice of SERM.

The following factors are well documented in the endocrinological literature:

  • Sleep 7–9 hours per night: Testosterone pulses above all during deep sleep. A meta-analysis in Sleep Medicine Reviews (2019) showed that sleep restriction to less than 5 hours lowered testosterone levels by 10-15% after just one week.

  • Calorie balance, not deficit: During PCT it is recommended to eat at maintenance level or with a small surplus. Severe caloric restriction activates cortisol, which directly suppresses gonadotropin release.

  • Zinc and vitamin D: Both are cofactors in testosterone synthesis. Deficiency of these is common and is easily corrected with standard supplements.

  • Low Intensity Strength Training: Heavy maximal lifting during PCT can increase cortisol levels disproportionately. Volume-based training with moderate weights is preferred.

  • Alcohol: Ethanol inhibits Leydig cell function directly and should be avoided completely during the PCT period.

A recovery line should be drawn from the end of the course: days 1–7 constitute the washout period for most SARMs (half-lives vary from 16 hours for RAD-140 to 24 hours for LGD-4033), and PCT is usually started on days 3–7 after the last dose, when the substance is sufficiently eliminated.

Frequently asked questions about PCT after SARMs

Do you always need PCT after a SARMs regimen?

Not necessarily in short, low-dose Ostarine courses, but it depends entirely on individual blood values. If LH and FSH are normal one week after the end of the course and testosterone has not fallen below the reference range, the body can recover without pharmacological intervention. For all stronger substances such as LGD, RAD-140 or stacked regimens, PCT is strongly recommended to avoid prolonged hypogonadism.

How long does it take for testosterone to normalize without PCT?

Based on available case reports and observational studies, spontaneous recovery from mild SARMs takes 4–8 weeks. After heavier regimens, it can take 3-6 months without intervention. With a well-executed PCT protocol, normalization is usually possible within 4–6 weeks, as confirmed in a number of BMJ Case Reports documentation from 2017–2022.

Can you use Nolvadex and Clomiphene at the same time?

Combination protocols are used and discussed within the research community, but they lack support in randomized controlled trials for SARMs-specific contexts. The risk of side effects increases when both are combined. If monotherapy does not work — visible in the form of remaining low LH/FSH after 2 weeks — it is a sign that medical contact should be sought rather than increasing the doses on one’s own.

What happens if you skip the PCT?

Consequences vary, but include: prolonged low-testosterone period with muscle loss, depression, fatigue, impaired sexual function, and potentially persistent hypogonadism requiring medical treatment. In one documented case (Urology Case Reports, 2020), TRT (testosterone replacement therapy) was required for 18 months after a SARMs regimen without subsequent PCT.

Are estrogen levels important to monitor during PCT?

Yes. Tamoxifen and clomiphene selectively affect estrogen receptors but do not alter aromatase activity. During PCT, estradiol can rise relative to testosterone, which can cause gynecomastia-related symptoms. Estradiol should be kept below 40 pg/mL. If the value is elevated — and there is actual glandular development, not just fat storage — a low-dose aromatase inhibitor can be discussed with a doctor, but is rarely necessary in SARMs-PCT.

Is it enough to just use natural testosterone boosters like PCT?

Products marketed as “natural PCT” or “test boosters” (ashwagandha, D-aspartic acid, etc.) do not provide a documented clinical effect on SARMs-induced suppression of the HPG axis. They can serve as an adjunct to lifestyle optimization, but do not replace pharmacological PCT in meaningful suppression. The blood tests decide — not the product descriptions.

Testosterone recovery after a SARMs regimen is a physiological process that requires the right timing, the right substance, and the right lifestyle support. The only objective measure is laboratory values ​​— not how you “feel” the week after completing the course. If the blood tests do not normalize within the expected time frame, it is a clear sign that an endocrinologist or other specialist should be consulted. Informed decisions always start with data.

.entry-content

Reviewed by

Dr. Carl Hedberg

HPLC Lead Scientist

Dr. Carl Hedberg is the HPLC analysis director of our independent chemical laboratory. He specializes in mass spectrometry, chromatography, and purity verification of performance-enhancing substances and peptides. All medical and dosage claims in this guide are audited for clinical accuracy.

Frequently Asked Questions